We prospectively investigated the effects of a course of electroconvulsive therapy (ECT) on neuroendocrine responses to serotonergic challenge in five depressed patients. Low dose intravenous chlorimipramine (CMI) challenge produced a modest release of prolactin and significant increases in plasma adrenocorticotrophic hormone (ACTH) and cortisol. Interestingly, ECT did not alter the neuroendocrine responses to serotonergic challenge despite clinical response in four of the five patients. If anything, the modest prolactin (PRL) response to CMI, rather than being enhanced, appeared to be abolished following ECT. Using confidence intervals, we estimate that there is less than a 5% probability of a 78% increase in prolactin response to CMI after ECT. To detect this, a sample size of greater than 35 would be needed. These findings suggest that neither ECT nor the clinical response in severely depressed patients is likely to produce consistent changes in neuroendocrine response to the acute serotonergic effects of CMI infusion. The lack of effect of ECT on prolactin response to serotonergic challenge might be explained by simultaneous enhancement of both serotonergic and dopaminergic neurotransmission.
Abrams R., Swartz C.M. (1985a) Electroconvulsive therapy and prolactin release: relation to treatment response in melancholia. Convulsive Ther1: 38-42
2.
Abrams R., Swartz C.M. (1985b) Electroconvulsive therapy and prolactin release: effects of stimulus parameters. Convulsive Ther1: 115-119
3.
Amsterdam J.D., Schweizer E., Winokur A. (1987) Multiple hormonal responses to insulin-induced hypoglycaemia in normal volunteers. Am J Psychiatr144: 170-175
4.
Aperia B., Bergman H., Engelbrekston K., Thoren M., Wetterberg L. (1985) Effects of electroconvulsive therapy on neuropsychological function and circulating levels of ACTH, cortisol, prolactin, and TSH in patients with major depressive illness. Acta Psychiatr Scand72: 536-541
5.
Balldin J., Granerus A.K., Lindstedt G., Modigh K., Walinder J. (1982) Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy. Psychopharmacology76: 371-376
6.
Bartko J.J., Pulver A.E., Carpenter W.T. (1988) The power of analysis: statistical perspectives . Part 2. Psychiatr Res23: 301-309
7.
Bettini E., Ceci A., Spinelli R., Samanin R. (1987) Neuroleptic-like effects of the L-isomer of fenfluramine on striatal dopamine release in freely moving rats. Biochem Pharmacol36: 2387-2391
8.
Bunney W.E. Jr, Hamburg D.A. (1963) Methods for reliable longitudinal observation of behavior. Arch Gen Psychiatr9: 280-294
9.
Charney D.S., Heninger G.R., Sternberg D.E. (1984) Serotonin function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. Arch Gen Psychiatr41: 359-365
10.
Coppen A., Rama V.A., Bishop M., Abou-Saleh M.T., Wood K. ( 1980) Neuroendocrine studies in affective disorders. Part 1. Plasma prolactin response to thyrotropin-releasing hormone in affective disorders: effect of ECT. J Affective Disord2: 311-315
11.
Costain D.W., Cowen P.J., Gelder M.G., Grahame-Smith D.G. (1982) Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses. Lancetii: 400-404
12.
Cowen P.J. (1988) Prolactin response to tryptophan during mianserin treatment. Am J Psychiatr145: 740-741
13.
Cowen P.J., Charig E. (1987) Neuroendocrine responses to intravenous tryptophan in major depression. Arch Gen Psychiatr44: 958-966
14.
Cowen P.J., Geaney D.P., Schachter M., Green A.R., Elliott J.M. (1986) Desipramine treatment in normal subjects. Effects on neuroendocrine responses to tryptophan and on platelet serotonin (5-HT)-related receptors. Arch Gen Psychiatr43: 61-67
15.
Deakin J.F., Ferrier I.N., Crow T.J., Johnstone E.C., Lawler P. (1983) Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcome. Br J Psychiatr143: 618-624
16.
DeMontigny C. (1984) Electroconvulsive treatments enhance responsiveness of forebrain neurons to serotonin. J Pharmacol Exp Ther228: 230-234
17.
Foresta C., Scanelli G., Indino M., Federspil G., Scandellari C. (1985) Naloxone reduces the fenfluramine-induced prolactin release in man. Clin Endocrinol22: 539-543
18.
Fuller R.W. (1981) Serotonergic stimulation of pituitary-adrenocortical function in rats. Neuroendocrinology32: 923-928
19.
Gartside S.E., Cowen P.J. (1990) Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors. Eur J Pharmacol179: 103-109
20.
Gillies G.E., Linton E.A., Lowry P.J. (1982) Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature299: 355-357
21.
Glue P.W., Cowen P.J., Nutt D.J., Kolakowska T., Grahame-Smith D.G. (1986) The effect of lithium on 5-HT mediated neuroendocrine responses and platelet 5-HT receptors. Psychopharmacology90: 398-402
22.
Golden R.N., Hsiao J., Lane E., Hicks R., Rogers S., Potter W.Z. (1989) The effects of intravenous clomipramine on neurohormones in normal subjects. J Clin Endocrinol Metab68: 632-637
23.
Golden R.N., Hsiao J., Lane E., Ekstrom R.D., Rogers S., Hicks R., Potter W.Z. (1990) Abnormal neuroendocrine responsivity to acute intravenous clomipramine challenge in depressed patients. Psychiatr Res31: 39-47
24.
Green A.R., Nutt D.J. (1987) Psychopharmacology of repeated seizures: possible relevance to the mechanism of action of electroconvulsive therapy. In Iversen L L, Iverson S D (eds), Handbook of psychopharmacology. Plenum Press, New York, pp. 375-419
25.
Grof E., Brown G.M., Grof P. ( 1982) Prolactin response to hypoglycemia in acute depression . Prog Neuropsychopharmacol Biol Psychiatr6: 487-490
26.
Hamilton M. (1960) A rating scale for depression. J Neurol Neurosurg Psychiatr23: 56-62
27.
Heninger G.R., Charney D.S., Sternberg DE (1984) Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects . Arch Gen Psychiatr41: 398-402
28.
Holmes M.C., DiRenzo G., Beckford U., Gillham B., Jones M.T. (1982) Role of serotonin in the control of secretion of corticotrophin releasing factor. J Endocrinol93: 151-160
29.
Huynh H., Feldt L.S. (1976) Estimation of the Box correction for degrees of freedom from sample data in the randomized block and split plot design. J Educ Stat1: 69-82
30.
Hyde J.F., Murai I., Ben-Jonathan N. (1987) The rat posterior pituitary contains a potent prolactin-releasing factor: studies with perfused anterior pituitary cells. Endocrinology121: 1531-1539
31.
Invernizzi R., Berettera C., Garattini S., Samanin R. (1986) D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur J Pharmacol120: 9-15
32.
Jori A., Benardi D. (1972) Further studies on the increase of striatal homovanillic acid induced by amphetamine and fenfluramine. Eur J Pharmacol19: 276-280
33.
Judd L.L., Risch S.C., Parker D.C., Janowsky D.S., Huey L.Y. (1982) Blunted prolactin response: a neuroendocrine abnormality manifested by depressed patients. Arch Gen Psychiatr39: 1413-1416
34.
Laakmann G., Chuang I., Gugath M., Ortner M., Schmauss M., Wittman M. (1983) Prolactin and antidepressants. In Tolis G (ed.), Prolactin and prolactinomas . Raven Press, New York, pp. 151-161
35.
Laakmann G., Gugath M., Kuss H.J., Zygan K. (1984a) Comparison of growth hormone and prolactin stimulation induced by chlorimipramine and desimipramine in man in connection with clorimipramine metabolism. Psychopharmacology82: 62-67
36.
Laakmann G., Whittman M., Gugeath M. (1984b) Effects of psychotrophic drugs (desipramine, chlorimipramine, sulpiride, and diazepam) on human HPA axis. Psychopharmacology84: 66-70
37.
Lamberts S.W., MacLeod R.M. (1990) Regulation of prolactin secretion at the level of the lactotroph. Physiol Rev70: 279-318
38.
Langer S.Z., Sechter D., Loo H. ( 1986) Electroconvulsive shock therapy and maximum binding of platelet tritiated imipramine binding in depression. Arch Gen Psychiatr43: 949-952
39.
Linkowski P., Brauman H., Mendlewicz J. (1980) Prolactin secretion in women with unipolar and bipolar depression. Psychiatr Res3: 265-272
40.
Linnoila M., Litovite G., Scheinin M., Chang M-D., Cutler N.R. (1984) Effects of electro-convulsive treatment on monoamine metabolites, growth hormone, and prolactin in plasma. Biol Psychiatr19: 79-84
41.
Manji H.K., Hsiao J.K., Risby E.D., Oliver J., Rudorfer M.V., Potter W.Z. (1991) The mechanisms of action of lithium. I. Effects on serotonergic and noradrenergic systems in normals. Arch Gen Psychiatr48: 505-512
42.
Meltzer H.Y., Lowy M.T. (1987) The serotonin hypothesis of depression. In Meltzer H Y (ed.), Psychopharmacology: the third generation of progress. Raven Press, New York, pp.513-526
43.
Meltzer H.Y., Gudelsky G.A., Simonovic M., Fang V.S. (1983) Effect of dopamine agonists and antagonists on prolactin and growth hormone secretion. In Carlsson A, Nilsson J L G (eds), Dopamine receptor agonists. Swedish Pharmaceutical Press , Stockholm, pp. 200-218
44.
Muller E.E., Locatelli V., Cellas S., Penalva A., Novelli A., Cocchi D. (1983) Prolactin-lowering and releasing drugs: mechanisms of action and their therapeutic applications. Drugs25: 399-432
45.
Muscettola G., Wehr T., Goodwin F. (1977) Effect of diet on urinary MHPG excretion in depressed patients and in normal controls. Am J Psychiatr134: 914-916
46.
Price L.H., Charney D.S., Heninger G.R. (1985) Effects of tranylcypromine treatment on neuroendocrine, behavioral, and autonomic responses to tryptophan in depressed patients. Life Sci37: 809-818
47.
Price L.H.Charney D.S., Heninger G.R. (1988) Effects of trazodone treatment on serotonergic function in depressed patients. Psychiatr Res24: 165-175
48.
Price L.H., Charney D.S., Delgado P.L., Anderson G.M., Heninger G.R. (1989a) Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan. Arch Gen Psychiatr46: 625-631
49.
Price L.H., Charney D.S., Delgado P.L., Heninger G.R. (1989b) Lithium treatment and serotonergic function: neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder. Arch Gen Psychiatr46: 13-19
50.
Quattrone A., Tedeschi G., Aguglia V., Scopacasa F., DiRenzo G.E., Annunziato L. (1983) Prolactin secretion in man: A useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurons. Studies with fenfluramine. Br J Clin Pharmacol16: 471-475
51.
Rausch J.L., Rich C.L., Risch S.C. (1988) Platelet serotonin transport after a single ECT . Psychopharmacology95: 139-141
52.
Rivier C., Vale, W. (1983) Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology113: 939-942
53.
Robertson A.G., Jackman H., Meltzer H.Y. (1984) Prolactin response to morphine in depression. Psychiatr Res11 : 353-364
54.
Rudorfer M.V., Risby E.D., Hsiao J.K., Linnoila M., Potter W.Z. (1988) Disparate biochemical actions of electroconvulsive therapy and antidepressant drugs. Convulsive Ther4: 133-140
55.
Shapira B., Gropp C., Lerer B. (1989a) ECT and imipramine enhance prolactin response to fenfluramine challenge. Biol Psychiatr25: 110A
56.
Shapira B., Reiss A., Kaiser N., Kindler S., Lerer B. (1989b) Effect of imipramine treatment on the prolactin response to fenfluramine and placebo challenge in depressed patients. J Affective Disord16: 1-4
57.
Siever L.J., Murphy D.L., Slater S., de la Vega E., Lipper S. (1984) Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Life Sci34: 1029-1039
58.
Siever L.J., Coccaro E.F., Benjamin E., Rubinstein K., David K.L. (1986) Adrenergic and serotonergic receptor responsiveness in depression. Ciba Found Symp123: 148-163
59.
Siever L.J., Murphy D.L., Slater S., De La Vega E., Lipper S. (1984) Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Life Sci34: 1029-1039
60.
Spitzer R.L., Endicott J., Robins E. (1978) Research diagnostic criteria: rationale and reliability . Arch Gen Psychiatr35: 773-778
61.
Tuomisto J., Mannisto P. (1985) Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev37: 249-332
62.
Vale W., Spiess J., Rivier C., Rivier J. (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates the secretion of corticotropin and β-endorphin . Science213: 1394-1397
63.
Vetulani J., Lebrecht U., Pilc A. ( 1981) Enhancement of responsiveness of the central serotonergic system and serotonin-2-receptor density in rat frontal cortex by electroconvulsive treatments. Eur J Pharmacol76: 81-85
64.
Weizman A., Mack M., Gil-Aid I., Tyano S., Laron Z. (1989) Plasma cortisol, prolactin, growth hormone and immunoactive β-endorphin response to fenfluramine challenge in depressed patients. Clin Neuropharmacol11: 750-756
65.
Whalley L.J., Eagles J.M., Bowler G M R, Bennie J.G., Dick H.R., McGuire R.J., Fink G. ( 1987) Selective effects of ECT on hypothalamic-pituitary activity . Psychol Med17: 319-328
66.
Willoughby J.O., Menadue M.F., Liebelt H. (1987) Activation of serotonin receptors in the medial base hypothalamus stimulates growth hormone secretion in the unanesthetized rat. Brain Res404: 319-322
67.
Willoughby JO, Menadue M.F., Liebelt H.J. (1988) Activation of 5-HT-1 serotonin receptors in the medial basal hypothalamus stimulates prolactin secretion in the unanaesthetized rat. Neuroendocrinology47: 83-87
68.
Witschy J.K., Schlesser M.A., Fulton C.L., Orsulak P.J., Giles D.E., Fairchild C., Crowley G., Rush A.J. (1984) TRH-induced prolactin release is blunted in females with endogenous unipolar major depression. Psychiatr Res12: 321-331
69.
Zis A.P., Manji H.K., Remick R.A. (1989) Effects of the 5HT2 antagonist ketanserin on the ECT-induced prolactin release. Biol Psychiatr26: 102-106
